Effect of slow-release β-alanine tablets on absorption kinetics and paresthesia
Effect of slow-release β-alanine tablets on absorption kinetics and paresthesia
About this item
Full title
Author / Creator
Publisher
Vienna: Springer Vienna
Journal title
Language
English
Formats
Publication information
Publisher
Vienna: Springer Vienna
Subjects
More information
Scope and Contents
Contents
Oral β-alanine (βA) doses larger than 800 mg commonly result in unpleasant sensory symptoms (paresthesia). However, the association of form (pure vs. slow-release) with side-effects has not been fully described. The aim of this single-blinded, randomized three-arm clinical trial was to compare plasma kinetics and symptoms following βA bolus adminis...
Alternative Titles
Full title
Effect of slow-release β-alanine tablets on absorption kinetics and paresthesia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1031328587
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1031328587
Other Identifiers
ISSN
0939-4451
E-ISSN
1438-2199
DOI
10.1007/s00726-011-1169-7
